EYPT icon

EyePoint Pharmaceuticals

145 hedge funds and large institutions have $553M invested in EyePoint Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 68 increasing their positions, 24 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
+7
Holders Change %
+5.07%
% of All Funds
1.93%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
29
Increased
68
Reduced
24
Closed
21
Calls
$2.28M
Puts
$2.46M
Net Calls
-$179K
Net Calls Change
-$2.7M
Name Holding Trade Value Shares
Change
Shares
Change %
TI
151
Trexquant Investment
Connecticut
-$347K -43,425 Closed
EC
152
EntryPoint Capital
New York
-$309K -38,700 Closed
GCP
153
GSA Capital Partners
United Kingdom
-$264K -32,979 Closed
SG Americas Securities
154
SG Americas Securities
New York
-$154K -19,303 Closed
GWM
155
Greenwich Wealth Management
Connecticut
-$93K -11,700 Closed
ECM
156
ExodusPoint Capital Management
New York
-$92K -11,468 Closed
EGM
157
Engineers Gate Manager
New York
-$89.6K -11,209 Closed
BHCM
158
Brevan Howard Capital Management
Jersey
-$86.1K -10,780 Closed
US Bancorp
159
US Bancorp
Minnesota
-$20.3K -2,535 Closed
ACM
160
ADAR1 Capital Management
Texas
-$16K -2,000 Closed
Acadian Asset Management
161
Acadian Asset Management
Massachusetts
-$14K -1,864 Closed
QT
162
Quantbot Technologies
New York
-$264 -33 Closed
Russell Investments Group
163
Russell Investments Group
United Kingdom
-$192 -24 Closed
AssetMark Inc
164
AssetMark Inc
California
-$120 -15 Closed